Available for semaglutide (Ozempic, Wegovy, Wegovy Pill, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Saxenda, Victoza), and dulaglutide (Trulicity)
This combination of effects is what makes GLP-1 therapies useful for blood sugar control and weight loss, and may also explain why researchers are now exploring their impact in other areas
Normal endogenous production of L-carnitine can be inadequate in patients with kidney disease, diabetes, liver dysfunction, hyperlipidemias, and cardiac problems, thus requiring supplementation
Still, right now, were not getting any signals that that is going to happen anytime soon, according to Zollo